Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: A case report and review of the literature

Authors

  • Krishna Dathan
  • V Lakhshmi

Keywords:

Acute renal failure, Oligohydramnios, Olmesartan medoxomil

Abstract

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers (ARBs) are widely used antihypertensive with well-recognized renoprotective and cardioprotective effects. Although treatment with these agents generally does not result in adverse metabolic consequences, their use during human pregnancy has been associated with negative reactions. Here, we report a premature baby with a history of oligohydramnios and maternal exposure to the ARB olmesartan medoxomil who was transferred to our institution with acute renal failure.

Downloads

Download data is not yet available.

Downloads

Published

2018-03-20

Issue

Section

Case Report

How to Cite

Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: A case report and review of the literature. (2018). Indian Journal of Case Reports, 4(2), 105-106. https://mansapublishers.com/index.php/ijcr/article/view/812

Most read articles by the same author(s)

<< < 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 > >>